Measuring progress in neglected disease drug development
Professor Joshua Cohen, Tufts University
February 6, 2015
Cervical cancer prevention, diagnosis, and treatment: Practicing evidence-based public health policy and practice in Cameroon
Dr. Javier Gordon Ogembo, UMass Medical School
October 17, 2014
Psychosocial constructions of the human papillomavirus vaccine (HPV) amongst young women in Scotland, Spain, Bulgaria, and Serbia
Dr. Carol Gray, Edinburgh Napier University
September 26, 2014
Giving well: Charity for Global Health
Professor Patricia Illingworth, Department of Philosophy & Religion
April 4, 2014
Egan 206
The need for new antibacterials to counter multi-drug resistance
Professor James Aggen, Department of Chemistry & Chemical Biology
March 21, 2014
Egan 206
Social Change and health in Eastern Europe, with a focus on cervical cancer
Professor Irina Todorova, Department of Health Sciences
February 28, 2014
Distributing rapid diagnostic tests for malaria through the private sector in Uganda
Professor William Dickens, Department of Economics
January 31, 2014
Microfluidic technologies for global health
Professor Shashi Murthy, Department of Chemical Engineering
December 13, 2013
Researching leishmaniasis in Kenya
Professor Richard Wamai, Department of African American Studies
November 15, 2013
Treatment as prevention for HIV-Focusing on intellectual property and market dynamics
Professor Brook Baker, School of Law
October 18, 2013
Doing research for the neglected: drug discovery for the diseases of the poor
Professor Michael Pollastri, Department of Chemistry & Chemical Biology
September 20, 2013
Learn how a range of health industries will contribute to a healthier world of the future, and consider how your career will move us toward that future.
Professional Forum: Career Paths in Global Health Boston Young Healthcare Professionals Thursday, January 24, 2013 5:30 – 7:30 pm Raytheon Amphitheater, Northeastern University 360 Huntington Ave, Boston, MA 02115
After the Storm: New Directions in Health Policy and Law
Friday, April 19, 2013 8:30-4:30 Raytheon Amphitheater, Northeastern University 360 Huntington Ave, Boston, MA 02115 http://www.northeastern.edu/law/academics/institutes/health-law/events/after-the-storm/
Chemical Biology and Lead Drug Discovery in the African Trypanosome
Tuesday, December 4, 2012 10 a.m. Professor Kojo Mensa-Wilmot, Ph.D. 440 Egan at Northeastern University College of Science Global Health Special Seminar
Drs. Halperin and Wamai will explore the science, practice and implementation of male circumcision and field the many questions regarding its potential as the “cutting edge” for preventing HIV infections.
For more information, click here!
Wednesday, November 28, 2012 12:00 p.m. Professor Richard Wamai, Ph.D. with guest Professor Daniel Halperin, Ph.D 94 Cargill at Northeastern University School of Law The Cutting Edge: Male Circumcision for HIV Prevention HIV/AIDS Policy Grand Rounds
Multiple and Intersecting Approaches to Developing Drugs for the ‘Neglected’ Tropical Diseases (From Targets to Screens and Back Again…)
Tuesday, November 20, 2012 10 a.m. Conor Caffrey, Ph.D. 440 Egan at Northeastern University College of Science Global Health Special Seminar
Mass Spectrometry Guided Medicinal Chemistry of Antimalarial and Anticancer Agents
Friday, November 16, 2012 10 a.m. Professor Roman Manetsch, PhD 440 Egan at Northeastern University College of Science Global Health Special Seminar
Optimizing the Response of Prevention: HIV Efficiency in Africa Project, Program on Health Policy and Law Faculty Roundtable
Monday, October 15, 2012 12:00 p.m. Northeastern University African American Studies Professor Richard Wamai, Ph.D Brown University Health Services Policy & Practice Professor Omar Galarraga 42 Dockser Hall at Northeastern University
Although tremendous advances have been made in our understanding and treatment of disease, major challenges remain in improving health for populations in the developing world. Complex issues such as inadequate therapies, poor infrastructure, governmental policy, and inadequate health care and education stifle progress. In the face of these multiple challenges, diseases that are endemic in developing nations are repeatedly ‘neglected’ by scientists and pharmaceutical companies based in developed nations. Of the 1,556 new drugs developed from 1975 to 2004, tropical diseases and TB accounted for only 1.3 percent of them, despite making up 12 percent of the world’s disease burden. There is hope for cures to some of the world’s neglected diseases through repurposing existing drugs and drug discovery knowledge, since many biochemical mechanisms in neglected diseases are shared with well-studied mechanisms in humans.
Find out how Northeastern is making a difference.
Miss the talk? Read some of what Professor Pollastri shared here and listen to the presentation here!
Friday, October 12, 2012 1 p.m. Chemistry Professor Michael Pollastri, Ph.D. Raytheon Amphitheater at Northeastern University Addressing Neglected Tropical Diseases, College of Science Colloquium